Viz Oncology integrates NCCN guidelines

Diving deeper into

Viz.ai

Company Report
the company has partnered with NCCN to embed clinical guidelines for breast, prostate, and bladder cancer directly into Viz Oncology workflows at the point of care.
Analyzed 4 sources

This partnership turns Viz Oncology from a routing tool into a treatment decision tool. Instead of only flagging a cancer patient and moving messages between radiology, oncology, and navigation teams, the workflow can now show the next recommended workup or treatment path for breast, prostate, and bladder cancer inside the same care coordination flow. That makes the software more useful in everyday oncology visits, where speed matters but guideline compliance also drives outcomes and reimbursement.1 2 3

  • Viz built its early business around stroke and other acute conditions, where the core value was getting the right specialist to the patient faster. The oncology suite extends that model into a longer, more repetitive workflow, where value comes from finding high risk patients early, coordinating follow up, and reducing missed guideline steps over weeks or months.1 2
  • NCCN content matters because many oncology decisions are not one off image reads. They are branching care pathways. A clinician may need to confirm stage, biomarker testing, prior therapy, and line of treatment before choosing the next step. Embedding guidelines in workflow software means those checks can happen while the team is already reviewing the case, not in a separate reference search.2 3
  • This also shows where competition is moving. OpenEvidence uses NCCN algorithms inside a clinician question and answer product, while Viz is putting guidelines inside hospital operations software tied to alerts, care team messaging, and patient progression through the system. One model helps answer a doctor’s question. The other tries to shape what happens next in the care process.3 4

The next step is deeper expansion from three tumor types into more cancers and more actions around each case, including documentation, prior authorization support, and therapy specific coordination with pharma partners. If Viz keeps pairing real time patient detection with embedded treatment logic, it can become part of the default operating system for how hospital oncology programs run.1 2